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The effect of combined modality treatment with ionising radiation and
TPPS-mediated photodynamic therapy on murine tail skin
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Paterson Institutefor Cancer Research, Christie Hospital & Holt Radium Institute, Manchester M20 9BX, UK.
Summary The effect on normal skin of combined modality treatment with 300 kV X-rays and photodynamic
therapy (PDT) using the photosensitising drug meso-tetra (sulphonatophenyl) porphine (TPPS) was studied
using the mouse tail necrosis assay. Prior treatment with a tolerance dose of PDT produced a significant
increase in the probability of necrosis following graded doses ofionising radiation. A tolerance dose of X-rays
administered prior to graded doses of PDT also produced a significant rise in the necrosis rate. TPPS appeared
to have a radiosensitising effect but, as the animals were kept in subdued light, the low dose of PDT they
therefore received may provide an alternative explanation. The effect of prolonging the interval between the
modalities on the necrosis rate did not appear to be related to the time course of either the changes in blood
flow produced by each modality, measured by xenon clearance studies or the development of the skin reaction
following X-ray irradiation.
Photodynamic therapy is based on the selective retention of
certain photosensitising drugs in tumours. Exposure of these
tumours to light results in activation of the drug and destruc-
tion of the tumour cells.
As a new modality of cancer therapy, PDT has usually
only been offered to patients in whom conventional
treatments, e.g. surgery, chemotherapy and radiotherapy
have been considered inappropriate, have been refused or
have failed. Many of the published clinical studies on PDT
therefore include patients who have received prior
radiotherapy for a range of malignancies, e.g. cutaneous or
subcutaneous metastatic breast carcinoma (Dougherty, 1981;
Schuh et al., 1987), vaginal recurrence of gynaecological
malignancy (Ward et al., 1982), superficial malignancies of
the head and neck and skin (Carruth & McKenzie, 1985),
advanced squamous bronchogenic carcinoma (Hugh-Jones &
Gardner, 1987), oesophageal cancer (Thomas et al., 1987)
and resistant lower urinary tract carcinoma (Nseyo et al.,
1987).
Schuh et al. (1987) commented that 'PDT offers the
capability to be used in conjunction with chemotherapy,
hormonal therapy, surgical excision and after radiation
therapy'. There are already reports of clinical trials where
PDT has been combined with radiotherapy in the initial
management of patients with malignant disease, e.g. in the
treatment of patients with cerebral gliomas (Kaye et al.,
1987); retinoblastomas (Ohnishi et al., 1986) and non-small
cell carcinomas of the bronchus (Lam et al., 1987). It is
therefore becoming increasingly important to understand the
limitations placed on such a combined approach by the
occurrence of normal tissue damage.
The experimental evidence available on combined treat-
ment with radiotherapy and PDT is conflicting. A study on
the interaction of PDT and gamma-irradiation with regard to
the clonogenicity of Chinese hamster ovary fibroblasts in
vitro by Bellnier & Dougherty (1986) observed that pretreat-
ment with one modality did not significantly alter the Do and
Dq of the survival curve obtained with the other. Similarly
only a simple additive effect was observed when X-ray and
photodynamic therapy was combined in the treatment of a
retinoblastoma-like tumour in rats (Winther et al., 1988;
Kostron et al., 1986), however, concluded that combined
modality treatment had a greater inhibiting effect on tumour
growth than either modality alone as a result of studies in a
rat glioma model. Graschew & Shopova (1986) also noted
significant enhancement of the therapeutic effect after com-
bined modality therapy as measured by inhibition of tumour
growth in a mouse sarcoma model.
There are few published data on the effect of combined
modality therapy on normal tissue damage. The aims of this
study were therefore: (i) to determine whether there was any
'interaction' between PDT and radiotherapy in the produc-
tion of normal tissue damage using the mouse tail necrosis
model; (ii) to investigate the effect of prolonging the time
interval between treatment with each modality on any
interaction observed; and (iii) if there was such an effect, to
see if it was related to the time course of changes in vascular
function following each modality or of the skin reaction
following radiotherapy.
Materials and methods
Mice
Female mice, 13-16 weeks old, of the albino strain Balbc
were used. The animals were housed in subdued lighting
conditions under a 12 h dark (18.00-06.00) 12 h light regime
(exposure range according to position in the holding room,
was 1.3-7 J cm-2 per 12 h light period). Animals were supp-
lied with food and water ad libitum.
Drug
Tetrasodium-meso-tetra (4-sulphonatophenyl) porphine do-
decahydrate, TPPS (Porphyrin Products, Utah), was dis-
solved in 0.9% saline. This compound had its main absorp-
tion peak in saline at 425 nm, with a minor peak at 640 nm.
A dose of 0.5 mg was injected in a volume of 0.2 ml via the
lateral tail vein. The animals were then housed in the dark
for 24 h.
Light source
A 100 W, 12 V quartz tungsten halogen lamp (Xenophot
HLX, Wotan, London) was used with a KGI infra-red filter
(Schott, Mainz). This produced a continuous spectrum over
the range 300-1,110nm, with peak spectral irradiance at
approximately 700nm. Optical lenses produced a circular
beam of uniform irradiance over a 2.5cm diameter (max-
imum fall-off was 10%). The power density on the central
axis at the treatment distance was 75mW cm2.
Light treatment
The mice were lightly restrained without anaesthesia in a
perspex container. The tube containing the tail was covered
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with black tape apart from the central 2.5 cm. The container
was positioned with this tube across the diameter of the light
beam. Surface temperature during illumination was measured
with a thermocouple and was found not to rise above 32.5°C.
In the experiments reported here, times quoted from PDT
always refer to the time from the light treatment.
Xenon clearance
The use of the xenon clearance technique for measurement of
blood flow in mouse tail skin has been described previously
(Benstead & Moore, 1988a,b). Blood flow in the tails was
stimulated 15 min before and during measurement by raising
ambient temperature to 37°C. The mice were restrained in a
perspex container and 5 pi of 133Xe in 0.9% saline was
injected intradermally into the distal end of the treated area.
The injection site was positioned under the centre of a scintil-
lation counter attached to a ratemeter and the activity was
recorded at 2 min intervals for a minimum of Omin. The
slope of the line obtained when the logarithm of the remain-
ing activity was plotted against time was a function of local
blood flow (Kety, 1949). Results were analysed by a com-
puter program to obtain the least squares best fit for the
exponential half time (T1) for xenon clearance.
X-ray irradiation
A 3 cm length of tail was irradiated with 250 kV X-rays at a
dose rate of 2 Gy min- . The proximal edge of the irradiated
area corresponded to the proximal edge of the light field in
animals treated with PDT. A constant temperature of 30°C
was maintained during irradiation by heat supplied from an
electrical coil under the horizontal disc which housed the tails
in radial holes. The temperature was controlled by a ther-
mostat with a thermometer check in mid-tail position.
Necrosis end-point
Animals were scored as suffering tail necrosis if there was
complete loss of the tail distal to treated area.
Experimental design
PDT only - probability ofnecrosis vs light dose There were
six mice in each experimental group and the experiments
were repeated once, the data being pooled. Following drug
injection, groups of mice were treated with doses of light in
the range 22.5-247.5 J cm-2 to 2.5 cm of tail, the dose being
increased by 22.5 Jcm-2 in successive groups. Mice were
kept for 70 days and the proportion of each group which
underwent tail necrosis was recorded.
X-ray irradiation only - probability of necrosis vs radiation
dose There were 12 mice in each experimental group.
Groups of mice were treated with X-ray irradiation to 3 cm
of tail, the doses varying from 25 to 37 Gy in steps of 2 Gy.
The dose was delivered as a single fraction. Mice were kept
for 70 days and the proportion in which the tail was lost was
recorded.
X-ray irradiation only - time course of development of skin
reaction The skin reactions of 12 mice treated with 37 Gy
to a 3 cm length of tail (a dose expected to produce a 100%
necrosis rate) were scored twice weekly for 8 weeks using an
arbitrary numerical scale, developed by Hendry (1980),
shown in Table I. The skin reaction was also scored in
separate groups of mice 1 day, I week, 3 weeks and 6 weeks
after irradiation with 25 Gy (expected to produce a necrosis
rate <5%).
Previous work by Hendry et al. (1982) had shown that the
maximum rate of recovery of resistance of mouse tails to
radionecrosis following a priming dose of X-rays occurs
between 3 and 4 weeks. At 6 weeks this had recovered to the
maximal post-irradiation level (Hendry, 1978).
Table I Scoring ofmurine tail skin reactions
Score Reaction appearing Reaction disappearing
0.5 Possibly different from Healed
normal
0.75 Slight colour change some Thin epidermis in part
epidermal thickening slight reddening
1.0 Thickened epidermis Reddening in healed
epidermis
1.25 Thickened epidermis Final stages of scab
with slight desquamation sloughing/some reddening
slight-dry desquamation
1.5 Moist or dry desquamation Small scab persisting/some
over small irradiated region dry desquamation
1.75 Desquamation over Smaller scab persisting
approximately half
irradiated area
2.0 Total moist desquamation Scab sloughing, still moist
in part
2.25 Scab forming, moist in parts Scab over part of
irradiated area.
2.5 Hard scab over >1 irradiated Hard scab persistent
area or constriction
2.75 Firm scab/slight bleeding Scab persistent/slight
oedema
3.0 Evidence of bleeding distal Distal tail oedema nearly
tail oedema severed
PDT only - time course of vascular changes There were 12
mice in each experimental group. Xenon clearance was per-
formed, as described, on either day 1 or day 5 following
PDT. Previous studies led us to expect impairment of blood
flow on day 1 with recovery occurring by day 5 (Benstead &
Moore, 1988a,b). A light dose of 90 J cm-2 was applied 24 h
following drug injection. This would be expected to produce
only a very low incidence of necrosis. Xenon clearance was
also performed on a control group of 12 untreated, age-
matched, female, Balbc mice.
X-ray irradiaton only - time course of vascular
changes Xenon clearance was performed, as described, on
groups of mice 1, 7, 21 and 42 days following irradiation
with 25 Gy. There were 12 mice in each experimental group.
The xenon clearance T1 values were also determined in a
control group of 12 untreated, age-matched, female, Balbc
mice.
Combined modality treatment - X-ray followed by
PDT Mouse tails were pretreated with 25 Gy to 3 cm,
which had been found to be a tolerance dose of irradiation.
The ED50 for animals treated with PDT to a 2.5 cm length of
tail within the area previously subjected to ionising irradia-
tion was then determined 1, 7, 21 or 42 days later. Following
drug injection, mice were irradiated with a range of six light
doses. There were 12 mice treated with each light dose and
72 mice treated at each interval after irradiaton. The animals
were kept for 70 days following PDT and the proportion of
mice undergoing tail necrosis was recorded.
Combined modality treatment - PDT followed by X-ray
irradiation Mouse tails were pretreated with PDT using a
light dose of 90 J cm-2 to 2.5 cm. The EDm for animals
treated with X-ray irradiation to 3 cm of tail, which included
the area previously treated with PDT, was then determined 1
and 5 days later. A range of six X-ray doses were employed.
There were 12 mice treated with each dose and therefore 72
mice treated at each interval after irradiation. The animals
were kept for 70 days and the proportion undergoing tail
necrosis was recorded.
Drug only, combined with X-ray irradiation Mice were
pretreated with 0.5 mg TPPS i.v. 48 h prior to X-ray irradia-
tion to 3 cm of tail. There were 12 mice in each group and50 K. BENSTEAD & J.V. MOORE
six dose levels were used. The animals were observed for 70
days for tail necrosis.
Light only, combined with X-ray irradiation There were 12
mice in each experimental group. All the animals received 90
J cm-2 of light to 2.5 cm of tail, 24 h prior to X-ray irradia-
tion. Six dose levels of ionising irradiation were employed.
They were then kept for 70 days and the proportion under-
going tail necrosis was recorded.
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Statistical analysis
Data comparing incidence of tail necrosis with light dose
were analysed by a probit fitting program (Gilbert, 1969) to
yield values for the ED", i.e. the light dose that causes a
50% incidence of necrosis in a group ofmice; and for 1/slope
of the probit curve, i.e. the increase in dose that causes a
reduction in tail survival from 84% to 50% or from 50% to
16%. Tail survival curves were compared by one-way
analysis of variance. The T, values calculated from the xenon
clearance experiments were normally distributed in the con-
trol groups and following X-ray irradiation therapy. They
were therefore compared by one-way analysis of variance. If
this revealed significant differences Duncan's test was applied
to pin-point the site of differences.
The results were positively skewed in some of the groups
treated with PDT. These data were therefore analysed by the
Kruskal-Wallis test, which if significant was followed by
multiple Mann-Whitney U tests using a reduced significance
level (Siegel, 1956).
Results
PDT only - probability ofnecrosis vs light dose
Probit analysis yielded an ED50 of 170 ± 3 J cm-2, with a
1/slope value of 50±3 J cm-3 (error as 1 s.e.), for female
Balbc mice injected with 0.5 mg TPPS (Porphyrin Products)
and irradiated with light 24 h later. By 30 days after irradia-
tion tail necrosis was complete, i.e. the ED50/30 and the ED50/70
were equal.
X-ray irradiation only - probability ofnecrosis vs radiation
dose
Probit analysis yielded an ED50/70 of 33.8 ± 0.4 Gy with a
1/slope value of 2.3 ± 0.4 Gy (error as 1 s.e.). Tail necrosis
did not occur more than 70 days post-irradiation.
X-ray irradiation only - time course ofdevelopment ofthe
skin reaction
Figure 1 shows the mean skin reaction scores, recorded
bi-weekly, for 12 mice treated with 37 Gy to a 3 cm length of
tail and at 1 day, 1 week, 3 weeks and 6 weeks after
irradiation, for 12 animals treated with 25 Gy. Where tail
necrosis had occurred, the score for the animal was recorded
as 3 for calculation of the subsequent means. Following 37
Gy no reaction was seen until 14 days. The reaction then
increased until by 39 days tail necrosis had occurred in all
the animals. No skin reaction was visible one week following
irradiation with 25 Gy. The mean score decreased between 3
and 6 weeks following this dose but this was not significant
(t test, P>0.05).
PDT only - time course ofvascular changes
The mean xenon clearance Tt (± 1 s.d.) values for female
Balbc mice were as follows: untreated controls 3.9±0.9 min;
1 day post-PDT 5.9±2.1 min; 5 days post-PDT 2.7±0.7 min
(where PDT consisted of 0.5 mg TPPS (Porphyrin Products)
i.v. and 90J cm2 of light 24 h later).
The Kruskal-Wallis test showed highly significant varia-
o 3700 cGy
o 2500 cGy
0 3 6
Weeks after XRT
Figure 1 The time course of the development of the skin re-
action following ionising radiation. Mean skin reaction scores ±
1 s.e. recorded in 12 Balbc mice following a single fraction to a
3 cm length of tail of either 37 Gy (0) or 25 Gy (0).
tion between these groups (P<0.0001). The Mann-Whitney
test revealed that both post-treatment values were
significantly different from the control value (P<0.01). The
results were therefore similar to those observed in B6D2F1
mice (Benstead & Moore, 1988a) with a reduction of blood
flow one day after PDT and a recovery by day 5, but in this
case the blood flow by day 5 was significantly greater than in
the control animals.
X-ray irradiation only - time course ofvascular changes
The mean xenon clearance T1 values in control animals and
at various times following X-ray irradiaton are shown in
Figure 2. Analysis of variance showed significant variation
between the groups. Duncan's test revealed that the T1 values
1 and 7 days following X-ray irradiation were significantly
lower than the control values but those after 3 weeks and 6
weeks did not differ significantly from controls.
Combined modality treatment - X-ray irradiationfollowedby
PDT
The ED50/30 and the ED50/70 were equal for animals treated
with PDT alone. As shown in Figure 3 this was not the case
for mice which had been pretreated with a tolerance dose of
X-ray irradiation. Comparison of the probability of necrosis
as a result of PDT alone with the probability of necrosis
following combined modality treatment showed that the
reduction in the ED50 values produced by pretreatment with
X-ray irradiation was highly significant, both when the ne-
crosis rate was scored at 30 days (P<0.02) and at 70 days
(P<0.0001). Changing the interval between X-ray irradiation
and PDT did not produce a significant change in the pro-
bability of necrosis even when the interval increased to 6
weeks.
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Figure 2 Changes in blood flow following exposure to X-rays.
Mean xenon clearance T1 ± I s.e. following treatment of 3 cm of
tail with 25 Gy at an ambient temperature of 30'C. The mean
value ± I s.e. obtained in experiments on untreated control
animals is also shown. 12 Balbc mice per point.
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Figure 3 Probability of necrosis following combined modality
treatment, X-ray irradiation followed by PDT. ED50/30 (± 1
s.e.); ED50/70 --- (± I s.e.) calculated for groups of Balbc mice
pretreated with 25 Gy of 300 kV X-rays to 3 cm of tail at an
ambient temperature of 30°C at a range of times prior to PDT to
2.5 cm of tail. The ED50/70 ± I s.e. for animals treated with PDT
alone is also shown (horizontal rule). 0.5 mg TPPS per mouse,
light irradiation 24 h later. 72 mice per point.
Combined modality treatment - PDTfollowed by X-ray
irradiation
The ED50/70 values (± 1 s.e.) observed following combined
modality treatment were: 1 day interval 25.2 ± 4.4 Gy; 5 day
interval 25.1 ± 2.1 Gy. This compares with a value of
33.8 ± 0.4 Gy when tails were treated with X-ray irradiation
alone. The increase in the probability of necrosis produced
by pretreatment with a tolerance dose of PDT was highly
significant: X-ray alone vs combined (1 day interval)
P<o.005; X-ray alone vs combined (5 day interval)
P<0.0005.
Drug only,followedby X-ray irradiation
The ED50/70 value calculated for animals which had received
0.5 mg TPPS (Porphyrin Products) i.v. 48 h prior to X-ray
irradiation was 30.6±0.7 Gy. This represented a significant
increase in the probability of necrosis compared with animals
treated with X-ray irradiation alone (P<0.05). The
differences between the EDm values obtained for those
animals which had been pretreated with drug only and those
which had received PDT prior to X-ray irradiation did not
reach significance when the interval between PDT and X-ray
irradiation was 1 day but were significant when the interval
was 5 days (P<0.05).
Light only,followed by X-ray irradiation
When animals were irradiated with 90 J cm-2 of light to
2.5 cm of tail, 24 h prior to X-ray irradiation, the ED-%/70 was
31.7 ±0.5 Gy. This was not significantly different from
animals which had been treated with X-rays alone. This
incidence of necrosis was significantly less than that observed
in the groups which had received PDT prior to X-ray irradia-
tion, both when the interval between PDT and radiotherapy
was 1 day (P<0.05) and when it was 5 days (P<0.01).
Discussion
The EDm value observed following irradiation of 3 cm of tail
with 300 kV X-rays at 30°C, 33.8 ±0.4 Gy, was comparable
with results obtained by Hendry (1978) following irradiation
of a 2 cm length of the tails of female B6D2F, mice at 28'C,
37.1 ± 1.2 Gy, and at 32°C, 33.9i± Gy. The time course of
the development of the skin reactions was also very similar.
Administration of TPPS (a hydrophilic photosensitiser)
alone, prior to radiotherapy decreased this ED50. Previous
studies on the 'interaction' of radiotherapy and photosensitis-
ing drugs have produced conflicting results. Moan & Petter-
son (1981) failed to observe any modifying effects of
haematoporphyrin or HPD (unlike TPPS, both lipophilic
photosensitisers) on the sensitivity of NHIK 3025 cells to 220
kV X-rays under aerobic conditions. Similarly, Bellnier &
Dougherty (1986) did not observe any change in the
radiosensitivity of Chinese hamster ovary fibroblasts when
they were pretreated with HPD. In contrast, however, i.p.
injection of HPD 48 h prior to gamma-irradiation produced
significant additional inhibition of tumour growth compared
to radiotherapy alone in an in vivo clonogenic assay of a rat
glioma model (Kostron et al., 1986). When the effect of these
treatments on the implanted tumours in the animals was
assessed by an in vitro clonogenic assay, potentiation was
again observed. In both assays the tumours were left on the
animal for 5 days after treatment. Surprisingly, treatment by
HPD alone, without ionising irradiation, produced inhibition
in the in vitro clonogenic assay. This might have been due to
the animals being housed in ambient light allowing a small
photodynamic effect to occur and calls into question whether
the observed potentiation of radiotherapy was truly indepen-
dent of a photodynamic effect. Zhao et al. (1986) reported
preliminary results from a clinical study on the use of HPD
as a sensitiser for radiotherapy of oral and maxillofacial
tumours. They claimed considerable enchancement of tumour
destruction. The controls, however, were historical and had
received a different radiotherapy schedule from the patients
receiving HPD. From the above discussion, no clear picture
emerges regarding the interaction of porphyrins 'alone' and
radiotherapy. In our experimental protocol, it is possible but
unlikely that the reduced ED,O was due to a PDT effect
caused by ambient lighting in the holding room. Light here
was at low dose-rate (1 mW cm-2, cf. 75 mW cm-2 for the
PDT exposures), with an absolute maximum daily dose of 7 J
cm 2 directly under the room lights (cf. the acute tolerance
dose of 90 J cm-2 for PDT). At no point were clinical signs
such as erythema or oedema observed in these animals,
which were retained for the overall duration of the longest
experiments, nor was there any increase at any time in xenon
T1 (Moore, unpublished).
Intentional PDT prior to graded doses of radiotherapy
produced a more marked decrease in the ED50 than adminis-
tration of drug alone. This reached significance at an interval
between PDT and X-ray treatment of 5 days. Experiments
reported previously (Benstead & Moore, 1988b) indicated
that the level of TPPS would not be expected to change in
mouse tail skin between 2 and 6 days after i.v. injection.
Therefore this significant difference was unlikely to be due to
an alteration in the level of the photosensitising drug. It
suggests there was an interaction between the two modalities
in the production of normal tissue damage, for which there
are several possible explanations.
Both modalities produce chromosomal damage. Gomer
(1980) observed DNA damage in the form of alkali-labile
lesions and single strand breaks in Chinese hamster ovary
cells treated with HPD phototherapy. Both X-rays and HPD
plus light were found to induce chromosomal aberrations in
NHIK cells (Evensen & Moan, 1982). If radiotherapy and
PDT interacted by both inducing damage in DNA, rather
than by a radiosensitising effect of the drug, then pretreat-
ment with a tolerance dose of X-irradiation might be
expected to increase the necrosis rate in mice treated with
graded doses of PDT. This is consistent with the results
observed here for TPPS (Figure 3). If the inhibition of repair
of X-ray induced DNA strand breaks by PDT, reported by
Boegheim et al. (1987) in vitro in murine fibroblasts, also
occurs in the present experimental system, this would poten-
tiate the interaction between the two modalities.
Alternatively, the increase in probability of necrosis with
combined modality therapy might be due to interaction of
the two modalities on the vascular system. Both produce
changes in blood flow as inferred by alterations in xenon Tt.
An increased blood flow on the first and seventh days after
X-irradiation as evidenced by the significant shortening in
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xenon T1 (Figure 2), might result in a rise in tissue oxygen
level in the tails, which are usually hypoxic at room
temperature (Hendry et al., 1976). In view of the dependence
of PDT on the presence of oxygen (Gomer & Razum, 1984),
pre-treatment with ionising radiation could thus lead to
sensitisation to subsequent PDT. Against this, however, is
the observation that the decreased ED50 persisted when the
interval between X-rays and PDT was prolonged to 3 and 6
weeks, although the blood flow had returned to control
levels.
If xenon T, is indeed predictive of impaired flow and
reduced oxygenation, then the increased T, at 1 day after
PDT might have been expected to lead to a rise in the ED,0
when the mice were treated at that time by X-rays, due to
hypoxia of the target cells (comparable to the additional
sparing of tail skin observed by Hendry (1978) on clamping
tail skin prior to X-irradiation). Similarly, a fall in ED50
might have been expected when the PDT interval was
extended to 5 days, in view ofthe improvement in blood flow
compared with control animals whose tails are, as we have
noted, normally moderately hypoxic (Hendry, 1978). In con-
trast to these expectations, a 'tolerance' dose of PDT prior to
X-irradiation produced a highly significant decrease in radia-
tion ED50 regardless of whether the interval between the two
modalities was 1 or 5 days. The interaction between the two
cannot therefore be explained on the basis of the altered
blood flow after PDT.
Rubin and Casarett (1968) postulated that late radiation
damage might be caused by leakage of plasma into the
interstitial space as a result of compromise of the endothelial
lining by irradiation. They suggested that this might
stimulate fibrosis, thus comprising function. Increased vas-
cular permeability, as revealed by the accumulation of intra-
venously administered radiolabelled albumin in tissues, has
been demonstrated following both PDT (Lim et al., 1985)
and X-irradiation (Krishnan et al., 1987). A histological
study reported by us previously (Benstead & Moore, 1989)
found that development of oedema exhibited different
dose-response curves following PDT, indicating that this
was probably not the main mechanism responsible for nec-
rosis following PDT alone. It is possible, however, that the
increase in interstitial fluid secondary to PDT might have an
additive effect with that due to X-irradiation, thus increasing
the probability of fibrosis and necrosis. This might provide
an explanation for the prolonged period over which necrosis
occurred following PDT in groups of mice which had been
pretreated with ionising radiation.
A further possibility is that in tails pretreated with X-rays,
the angiogenic response following PDT using TPPS reported
previously (Benstead and Moore, 1989), by stimulating
endothelial cells to divide, caused them to express potentially
lethal damage induced by the X-rays. Endothelial cell death
would prevent the recovery in blood flow normally observed
following PDT, more endothelial cells might be stimulated to
divide, causing yet more cell death, and so on in an ava-
lanche effect. Reversing the combination, pretreatment by
PDT 1 or 5 days prior to X-rays, might be expected to
produce an increase in the proportion of dividing endothelial
cells, which would express potentially lethal damage subse-
quent to irradiation, and hence reduce the ED50 for damage
to the dependent parenchyma.
In summary, combined modality treatment by PDT (with
TPPS and full-spectrum light) and X-irradiation resulted in
an increased incidence of necrosis of normal tissues. TPPS
appeared to have a radiosensitising effect although we cannot
yet definitively rule out a PDT effect mediated by the sub-
dued ambient light under which the mice were housed. The
effect of prolonging the interval between modalities on the
necrosis rate, did not appear to be related to the time course
of either the changes in blood flow (measured by xenon
clearance) or the skin reactions following X-irradiation. Fur-
ther experiments are underway to determine the precise
mechanism(s) of interaction, but it is clear that dose-
modificaton may be necessary if an unacceptable level of
normal tissue injury is to be avoided following this combina-
tion of modalities.
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